These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33023843)

  • 1. Escherichia coli FimH adhesins act synergistically with PapGII adhesins for enhancing establishment and maintenance of kidney infection.
    Tseng CC; Lin WH; Wu AB; Wang MC; Teng CH; Wu JJ
    J Microbiol Immunol Infect; 2022 Feb; 55(1):44-50. PubMed ID: 33023843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys.
    Tseng CC; Huang JJ; Wang MC; Wu AB; Ko WC; Chen WC; Wu JJ
    Kidney Int; 2007 Apr; 71(8):764-70. PubMed ID: 17290293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
    Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
    Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A host receptor enables type 1 pilus-mediated pathogenesis of Escherichia coli pyelonephritis.
    McLellan LK; McAllaster MR; Kim AS; Tóthová Ľ; Olson PD; Pinkner JS; Daugherty AL; Hreha TN; Janetka JW; Fremont DH; Hultgren SJ; Virgin HW; Hunstad DA
    PLoS Pathog; 2021 Jan; 17(1):e1009314. PubMed ID: 33513212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and development of FimH lectin domain for rising immune response after injection by uropathogenic E. coli.
    Zandi M; Fallah Mehrabadi J; Mahdavi M; Irani S
    Hum Antibodies; 2020; 28(2):169-178. PubMed ID: 32116244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.
    Rosen DA; Pinkner JS; Walker JN; Elam JS; Jones JM; Hultgren SJ
    Infect Immun; 2008 Jul; 76(7):3346-56. PubMed ID: 18474655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.
    Chen SL; Hung CS; Pinkner JS; Walker JN; Cusumano CK; Li Z; Bouckaert J; Gordon JI; Hultgren SJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22439-44. PubMed ID: 20018753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
    Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tracheal colonization in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli MT78 with a fimH deletion.
    Arné P; Marc D; Brée A; Schouler C; Dho-Moulin M
    Avian Dis; 2000; 44(2):343-55. PubMed ID: 10879915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.
    Nielsen KL; Stegger M; Kiil K; Godfrey PA; Feldgarden M; Lilje B; Andersen PS; Frimodt-Møller N
    Int J Med Microbiol; 2017 Dec; 307(8):497-507. PubMed ID: 29031453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional characterization of the FimH adhesin of uropathogenic Escherichia coli and its novel applications.
    Foroogh N; Rezvan M; Ahmad K; Mahmood S
    Microb Pathog; 2021 Dec; 161(Pt B):105288. PubMed ID: 34780972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
    J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.
    Willner D; Low S; Steen JA; George N; Nimmo GR; Schembri MA; Hugenholtz P
    mBio; 2014 Feb; 5(2):e01064-13. PubMed ID: 24570371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response.
    Dreux N; Denizot J; Martinez-Medina M; Mellmann A; Billig M; Kisiela D; Chattopadhyay S; Sokurenko E; Neut C; Gower-Rousseau C; Colombel JF; Bonnet R; Darfeuille-Michaud A; Barnich N
    PLoS Pathog; 2013 Jan; 9(1):e1003141. PubMed ID: 23358328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of adhesion to bacterial persistence in the mouse urinary tract.
    Hagberg L; Hull R; Hull S; Falkow S; Freter R; Svanborg Edén C
    Infect Immun; 1983 Apr; 40(1):265-72. PubMed ID: 6131870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.